These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 5510856)

  • 41. [A few cases illustrating the hazards of MAOI antidepressive agents].
    Boudin G; Lauras A
    Therapie; 1965; 20(5):1241-8. PubMed ID: 5850103
    [No Abstract]   [Full Text] [Related]  

  • 42. Incidence and significance of chlorpromazine-induced eye changes.
    De Long SL
    Dis Nerv Syst; 1968 Mar; 29(3):Suppl:19-22. PubMed ID: 4876741
    [No Abstract]   [Full Text] [Related]  

  • 43. Chlorpromazine.
    Macri F
    Eye Ear Nose Throat Mon; 1971 Mar; 50(3):111-2. PubMed ID: 5552871
    [No Abstract]   [Full Text] [Related]  

  • 44. [Rational use of antidepressants in general medicine].
    Verbanck P; Cnockaert P
    Rev Med Brux; 1996 Sep; 17(4):224-9. PubMed ID: 8927850
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Toxic effect of certain drugs on the organ of vision].
    Trzcińska-Dabrowska Z; Mroczek-Madziar D
    Pol Tyg Lek; 1967 Oct; 22(40):1538-41. PubMed ID: 4863223
    [No Abstract]   [Full Text] [Related]  

  • 46. Treating affective disorders in the presence of cardiovascular disease.
    Jefferson JW
    Psychiatr Clin North Am; 1983 Mar; 6(1):141-55. PubMed ID: 6889170
    [No Abstract]   [Full Text] [Related]  

  • 47. Phenothiazines and eye complications.
    Valentine M; Jardine P
    Br Med J; 1966 Sep; 2(5513):586. PubMed ID: 5917372
    [No Abstract]   [Full Text] [Related]  

  • 48. Continuation and maintenance treatments in major depression: the neglected role of monoamine oxidase inhibitors.
    Kennedy SH
    J Psychiatry Neurosci; 1997 Mar; 22(2):127-31. PubMed ID: 9074307
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cutaneous and ocular changes associated with the use of chlorpromazine.
    Wolf ME; Richer S; Berk MA; Mosnaim AD
    Int J Clin Pharmacol Ther Toxicol; 1993 Aug; 31(8):365-7. PubMed ID: 8225679
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Psychopharmacology: medical strategy and tactics].
    Koupernik C
    Evol Psychiatr (Paris); 1966; 31(4):661-80. PubMed ID: 4861895
    [No Abstract]   [Full Text] [Related]  

  • 51. [Treatment of depressive disorders].
    Saiz Ruiz J; Ibáñez Cuadrado A
    Rev Clin Esp; 1997 Nov; 197 Suppl 3():35-43. PubMed ID: 9477689
    [No Abstract]   [Full Text] [Related]  

  • 52. [Aurorix--an antidepressant with a wide spectrum of action].
    Iakovlev VA
    Voen Med Zh; 1998 Apr; 319(4):50-2. PubMed ID: 9633256
    [No Abstract]   [Full Text] [Related]  

  • 53. [Optic neuritis caused by monoamine oxidase inhibitors].
    Sourdille MJ
    Bull Soc Ophtalmol Fr; 1964 Dec; 64(12):981-8. PubMed ID: 5827828
    [No Abstract]   [Full Text] [Related]  

  • 54. [Ultrastructural study of corneal thickening in the course of chlorpromazine treatment].
    Pouliquen Y; Graf B; Bisson J; Feuvrier YM; Delattre A
    Arch Ophtalmol Rev Gen Ophtalmol; 1970 Nov; 30(11):769-82. PubMed ID: 4250388
    [No Abstract]   [Full Text] [Related]  

  • 55. Results of the STAR*D study: implications for clinicians and drug developers.
    Preskorn SH
    J Psychiatr Pract; 2009 Jan; 15(1):45-9. PubMed ID: 19182564
    [No Abstract]   [Full Text] [Related]  

  • 56. Ocular complications of chlorpromazine therapy.
    Petrohelos MA; Tricoulis D
    Ophthalmologica; 1969; 159(1):31-8. PubMed ID: 4984273
    [No Abstract]   [Full Text] [Related]  

  • 57. Ocular complications of systemic medications.
    Ellis PP
    Tex Med; 1971 Apr; 67(4):70-3. PubMed ID: 5552586
    [No Abstract]   [Full Text] [Related]  

  • 58. Chlorpromazine ocular toxicity.
    Johnson AW
    N C Med J; 1967 Nov; 28(11):474-6. PubMed ID: 5235902
    [No Abstract]   [Full Text] [Related]  

  • 59. Moclobemide response in depressed patients: association study with a functional polymorphism in the monoamine oxidase A promoter.
    Müller DJ; Schulze TG; Macciardi F; Ohlraun S; Gross MM; Scherk H; Neidt H; Syagailo YV; Grässle M; Nöthen MM; Maier W; Lesch KP; Rietschel M
    Pharmacopsychiatry; 2002 Jul; 35(4):157-8. PubMed ID: 12163988
    [No Abstract]   [Full Text] [Related]  

  • 60. [Adverse effects and complications of antidepressive chemotherapy].
    Loo H; Bousser MG
    Cah Med; 1972 Sep; 13(10):777-94. PubMed ID: 4566411
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.